CoChat

Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells

Open access
Harimoto, Hirotomo, Shimizu, Masumi, Nakagawa, Yohko, Nakatsuka, Katsuhisa, Wakabayashi, Ayako, Sakamoto, Choitsu, Takahashi, Hidemi · 2013 · Immunology & Cell Biology
Cited by 99

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Cancer immunosurveillance failure is largely attributed to the insufficient activation of tumor‐specific class I major histocompatibility complex (MHC) molecule (MHC‐I)‐restricted CD8+ cytotoxic T lymphocytes (CTLs). DEC‐205+ dendritic cells (DCs), having the ability to cross‐present, can present captured tumor antigens on MHC‐I alongside costimulatory molecules, inducing the priming and activation of tumor‐specific CD8+ CTLs. It has been suggested that reduced levels of costimulatory molecules on DCs may be a cause of impaired CTL induction and that some tumors may induce the downregulation of costimulatory molecules on tolerogenic DCs. To examine such possibilities, we established two distinct types of murine hepatoma cell lines, named Hepa1‐6‐1 and Hepa1‐6‐2 (derived from Hepa1‐6 cells), and confirmed that they display similar antigenicities, as well as identical surface expression of MHC‐I. We found that Hepa1‐6‐1 had the ability to grow continuously after subcutaneous implantation into syngeneic C57BL/6 mice and did not prime CD8+ CTLs. In contrast, Hepa1‐6‐2 cells, which display reduced levels of adhesion molecules, such as Intercellular Adhesion Molecule 1 (ICAM‐1), failed to grow in vivo and efficiently primed CTLs. Moreover, Hepa1‐6‐1‐derived factors, such as transforming growth factor (TGF)‐β1, vascular endothelial growth factor (VEGF) and α‐fetoprotein (AFP), converted CD11c high MHC‐II high DEC‐205+ DC subsets into tolerogenic cells, displaying downregulated costimulatory molecules and having impaired cross‐presenting capacities. These immunosuppressive tolerogenic DCs appeared to inhibit the induction of tumor‐specific CD8+ CTLs and suppress their cytotoxic functions within the tumor. Together, the findings presented here provide a new method of cancer immunotherapy using the selective suppression, depletion or alteration of immunosuppressive tolerogenic DCs within tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/icb.2013.38

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Harimoto, H., Shimizu, M., Nakagawa, Y., Nakatsuka, K., Wakabayashi, A., Sakamoto, C., & Takahashi, H.
Venue
Immunology & Cell Biology
Publisher
Wiley
Published
2013-09-10
Volume
91
Issue
9
Pages
545-555
ISSN
  • 0004-945X (ISSN-L)
  • 0818-9641
  • 1440-1711
OpenAlex
W1994024849
Cited by
99
References
1
FWCI
3.15
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.